We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
GSK to buy cancer drugmaker Tesaro for US$5.1 billion
Finance Finance Headlines News
GlaxoSmithKline said on Monday it had agreed to buy U.S. cancer drug specialist Tesaro for US$5.1 billion, marking a major biotech investment by ...